Abstract:The yeast null mutant smf1⌬ cannot grow on medium containing EGTA. Expression of Smf1p or the mammalian transporter DCT1 (Slc11a2) suppresses the above-mentioned phenotype. Both can also be expressed in Xenopus oocytes, and the uptake activity and their electrophysiological properties can be studied. We used these systems to analyze the properties of mutations in the predicted external loop I of DCT1. The sensitivity of the transporter to amino acid substitutions in this region is manifested by the mutation G1… Show more
“…Both use protons as their motive force to transport a broad-range of the same divalent metal ions and exhibit similar affinities for their various substrates (8,12,16). The mammalian DCT1 complements the phenotype of SMF1 null mutation in yeast (5,(17)(18)(19). The null mutant smf1⌬ is unable to grow in the presence of EGTA.…”
Section: Resultsmentioning
confidence: 99%
“…The differences between the two homologues have to be due to the non-conserved amino acids in both proteins. Consequently, to locate the sites on the transporters responsible for this phenomenon, we substituted amino acids in DCT1 for the corresponding ones residing in Smf1p (19). It has been found that a mutation in the conserved glycine at position 216 (G216R) in the putative TM4 of DCT1 causes microcytic anemia in mkϪ/Ϫ mice and Belgrade rats (20).…”
Metal ion transport by DCT1, a member of the natural resistance-associated macrophage protein family, is driven by protons. The stoichiometry of the proton to metal ion is variable, and under optimal transport conditions, more than 10 protons are co-transported with a single metal ion. To understand this phenomenon better, we used site-directed mutagenesis of DCT1 and analyzed the mutants by complementation of yeast suppressor of mitochondria import function-null mutants and electrophysiology with Xenopus oocytes. The mutation F227I resulted in an increase of up to 14-fold in the ratio between metal ions to protons transported. This observation suggests that low metal ion to proton transport of DCT1 resulting from a proton slippage is not a necessity of the transport mechanism in which positively charged protons are driving two positive charges of the metal ion in the same direction. It supports the idea that the proton slippage has a physiological advantage, and the proton slip was positively selected during the evolution of DCT1.Metal ions are vital elements for all living cells. The NRAMP 1 family of metal ion transporters apparently plays a major role in metal ion homeostasis (1-4). Most of the information available about the mechanism of these transporters has resulted from studies of the family members NRAMP2 (DCT1) from mammalian and SMF1 from yeast expressed in Xenopus oocyte (5-9). Xenopus oocytes have a very low metal ion uptake background, which makes them the ideal heterologous expression system for metal ion transporters. In addition to the uptake measurements of the various divalent cations, it is possible to analyze the electrophysiological parameters generated by imposed potentials in the transporter-expressing oocyte as compared with control (10). The studies of DCT1 and Smf1p demonstrated that both of them function as general divalent metal ion transporters and that a proton gradient is the driving force for the metal ion transport (8, 9). However, the transport of protons and metal ions is "loosely coupled" because the process exhibits a variable stoichiometry. At pH 7 and membrane potentials of Ϫ90 to Ϫ30 mV, DCT1 transports one Fe 2ϩ ion with one H ϩ . At high proton concentration (low pH), the number of H ϩ ions transported with one Fe 2ϩ ion increased to 10 (8). Moreover, on changing the membrane potential from ϩ10 to Ϫ80 mV at this low pH, the number of H ϩ ions transported with one Fe 2ϩ ion increased from 3 to ϳ18 (9). In DCT1, this phenomenon was defined as a metal ion-dependent proton slippage (1, 9, 11). In contrast to DCT1, Smf1p showed a metal ion-independent sodium slip through the proton-translocating pathway (9, 12). The mechanism of this phenomenon is not well characterized, and the sites on the transporters that generate it are not known.In this work, we addressed the coupling between proton and metal ion transport, and report on a mutation in DCT1 that exhibits an ϳ14-fold increase in the ratio of metal ion to proton transport.
MATERIALS AND METHODSSite-directed Mutagenesis o...
“…Both use protons as their motive force to transport a broad-range of the same divalent metal ions and exhibit similar affinities for their various substrates (8,12,16). The mammalian DCT1 complements the phenotype of SMF1 null mutation in yeast (5,(17)(18)(19). The null mutant smf1⌬ is unable to grow in the presence of EGTA.…”
Section: Resultsmentioning
confidence: 99%
“…The differences between the two homologues have to be due to the non-conserved amino acids in both proteins. Consequently, to locate the sites on the transporters responsible for this phenomenon, we substituted amino acids in DCT1 for the corresponding ones residing in Smf1p (19). It has been found that a mutation in the conserved glycine at position 216 (G216R) in the putative TM4 of DCT1 causes microcytic anemia in mkϪ/Ϫ mice and Belgrade rats (20).…”
Metal ion transport by DCT1, a member of the natural resistance-associated macrophage protein family, is driven by protons. The stoichiometry of the proton to metal ion is variable, and under optimal transport conditions, more than 10 protons are co-transported with a single metal ion. To understand this phenomenon better, we used site-directed mutagenesis of DCT1 and analyzed the mutants by complementation of yeast suppressor of mitochondria import function-null mutants and electrophysiology with Xenopus oocytes. The mutation F227I resulted in an increase of up to 14-fold in the ratio between metal ions to protons transported. This observation suggests that low metal ion to proton transport of DCT1 resulting from a proton slippage is not a necessity of the transport mechanism in which positively charged protons are driving two positive charges of the metal ion in the same direction. It supports the idea that the proton slippage has a physiological advantage, and the proton slip was positively selected during the evolution of DCT1.Metal ions are vital elements for all living cells. The NRAMP 1 family of metal ion transporters apparently plays a major role in metal ion homeostasis (1-4). Most of the information available about the mechanism of these transporters has resulted from studies of the family members NRAMP2 (DCT1) from mammalian and SMF1 from yeast expressed in Xenopus oocyte (5-9). Xenopus oocytes have a very low metal ion uptake background, which makes them the ideal heterologous expression system for metal ion transporters. In addition to the uptake measurements of the various divalent cations, it is possible to analyze the electrophysiological parameters generated by imposed potentials in the transporter-expressing oocyte as compared with control (10). The studies of DCT1 and Smf1p demonstrated that both of them function as general divalent metal ion transporters and that a proton gradient is the driving force for the metal ion transport (8, 9). However, the transport of protons and metal ions is "loosely coupled" because the process exhibits a variable stoichiometry. At pH 7 and membrane potentials of Ϫ90 to Ϫ30 mV, DCT1 transports one Fe 2ϩ ion with one H ϩ . At high proton concentration (low pH), the number of H ϩ ions transported with one Fe 2ϩ ion increased to 10 (8). Moreover, on changing the membrane potential from ϩ10 to Ϫ80 mV at this low pH, the number of H ϩ ions transported with one Fe 2ϩ ion increased from 3 to ϳ18 (9). In DCT1, this phenomenon was defined as a metal ion-dependent proton slippage (1, 9, 11). In contrast to DCT1, Smf1p showed a metal ion-independent sodium slip through the proton-translocating pathway (9, 12). The mechanism of this phenomenon is not well characterized, and the sites on the transporters that generate it are not known.In this work, we addressed the coupling between proton and metal ion transport, and report on a mutation in DCT1 that exhibits an ϳ14-fold increase in the ratio of metal ion to proton transport.
MATERIALS AND METHODSSite-directed Mutagenesis o...
“…The TMS1 Asp residue is part of a conserved DPGN motif that has been subjected to mutagenesis in studies using MntH or Nramp2 homologs, which showed loss of Me 2ϩ uptake caused by Gly exchange (11,47). The carboxyl end of Nramp2 TMS1 and adjacent extra loop were implicated in Me 2ϩ binding and coupling of Me 2ϩ uptake to the proton-motive force ((C/S/T)P(C/H)) that is conserved in the TMS6 of P 1B -type ATPases, which pump heavy metal cations using energy provided by ATP hydrolysis (48,49).…”
“…Measurement of leucine uptake: The method described in cued by a tor1 allele defective in rapamycin binding: If Karagiannis et al (1999) was followed with slight modifications adopted from Cohen et al (2003). rapamycin sensitivity in auxotrophs is the result of TOR or ⌬tor1 cells (TA390) were grown to log phase in minimal inhibition by FKBP12-rapamcin, it is expected that mumedium.…”
Section: Rapamycin Sensitivity Of Leucine Auxotrophs Is Res-mentioning
TOR protein kinases are key regulators of cell growth in eukaryotes. TOR is also known as the target protein for the immunosuppressive and potentially anticancer drug rapamycin. The fission yeast Schizosaccharomyces pombe has two TOR homologs. tor1 ϩ is required under starvation and a variety of stresses, while tor2 ϩ is an essential gene. Surprisingly, to date no rapamycin-sensitive TOR-dependent function has been identified in S. pombe. Herein, we show that S. pombe auxotrophs, in particular leucine auxotrophs, are sensitive to rapamycin. This sensitivity is suppressed by deletion of the S. pombe FKBP12 or by introducing a rapamycin-binding defective tor1 allele, suggesting that rapamycin inhibits a tor1p-dependent function. Sensitivity of leucine auxotrophs to rapamycin is observed when ammonia is used as the nitrogen source and can be suppressed by its replacement with proline. Consistently, using radioactive labeled leucine, we show that cells treated with rapamycin or disrupted for tor1 ϩ are defective in leucine uptake when the nitrogen source is ammonia but not proline. Recently, it has been reported that tsc1 ϩ and tsc2 ϩ , the S. pombe homologs for the mammalian TSC1 and TSC2, are also defective in leucine uptake. TSC1 and TSC2 may antagonize TOR signaling in mammalian cells and Drosophila. We show that reduction of leucine uptake in tor1 mutants is correlated with decreased expression of three putative amino acid permeases that are also downregulated in tsc1 or tsc2. These findings suggest a possible mechanism for regulation of leucine uptake by tor1p and indicate that tor1p, as well as tsc1p and tsc2p, positively regulates leucine uptake in S. pombe. inhibits TOR kinases when in complex with FKBP12, a PI-3 and PI-4 kinases and are therefore referred to as PI3K-ubiquitous 12-kD prolyl-isomerase. The inhibition of related kinases. Accumulation of data in yeast, Drosophila, TOR by FKBP12-rapamycin complexes accounts for the and mammalian cells suggests that TOR is a central inhibition of many growth-related functions that are regulator of cellular growth. TOR controls growth in TOR dependent. Nevertheless, rapamycin also affects response to changes in the environment, particularly cellular processes through direct inhibition of the cellunutrient availability and cellular energetic status. et al. (1996) strates that rapamycin does not inhibit all TOR kinase- 1996) vation. tor1 ϩ is also required for growth at extreme tem-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.